CN115005344A - Dietary supplement beverage and preparation method thereof - Google Patents
Dietary supplement beverage and preparation method thereof Download PDFInfo
- Publication number
- CN115005344A CN115005344A CN202210514918.2A CN202210514918A CN115005344A CN 115005344 A CN115005344 A CN 115005344A CN 202210514918 A CN202210514918 A CN 202210514918A CN 115005344 A CN115005344 A CN 115005344A
- Authority
- CN
- China
- Prior art keywords
- parts
- dietary supplement
- theanine
- extract
- notoginseng
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 29
- 235000015872 dietary supplement Nutrition 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title abstract description 13
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 claims abstract description 80
- 229940026510 theanine Drugs 0.000 claims abstract description 39
- 244000269722 Thea sinensis Species 0.000 claims abstract description 30
- 239000000284 extract Substances 0.000 claims abstract description 30
- 229930189775 mogroside Natural products 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 19
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims abstract description 16
- 235000013305 food Nutrition 0.000 claims abstract description 14
- 238000011049 filling Methods 0.000 claims abstract description 11
- 238000001914 filtration Methods 0.000 claims abstract description 11
- 230000001954 sterilising effect Effects 0.000 claims abstract description 11
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000006468 Thea sinensis Nutrition 0.000 claims abstract description 10
- 235000020279 black tea Nutrition 0.000 claims abstract description 10
- 239000000706 filtrate Substances 0.000 claims abstract description 10
- 238000005303 weighing Methods 0.000 claims abstract description 10
- 244000185386 Thladiantha grosvenorii Species 0.000 claims abstract description 9
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229910052782 aluminium Inorganic materials 0.000 claims abstract description 7
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 7
- 235000009569 green tea Nutrition 0.000 claims abstract description 7
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 6
- 235000020688 green tea extract Nutrition 0.000 claims abstract description 6
- 229940094952 green tea extract Drugs 0.000 claims abstract description 6
- 229910052742 iron Inorganic materials 0.000 claims abstract description 5
- 230000001105 regulatory effect Effects 0.000 claims abstract description 3
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 27
- 241000180649 Panax notoginseng Species 0.000 claims description 27
- 239000000843 powder Substances 0.000 claims description 17
- 229930182490 saponin Natural products 0.000 claims description 14
- 150000007949 saponins Chemical class 0.000 claims description 14
- 235000017709 saponins Nutrition 0.000 claims description 14
- 235000010987 pectin Nutrition 0.000 claims description 12
- 239000001814 pectin Substances 0.000 claims description 12
- 229920001277 pectin Polymers 0.000 claims description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 8
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 6
- 229920001542 oligosaccharide Polymers 0.000 claims description 6
- 229930189092 Notoginsenoside Natural products 0.000 claims description 5
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims description 5
- 239000001509 sodium citrate Substances 0.000 claims description 5
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 5
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 claims description 4
- 235000002791 Panax Nutrition 0.000 claims description 4
- 241000208343 Panax Species 0.000 claims description 4
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 4
- 235000002949 phytic acid Nutrition 0.000 claims description 4
- 239000000467 phytic acid Substances 0.000 claims description 4
- 229940068041 phytic acid Drugs 0.000 claims description 4
- 235000011083 sodium citrates Nutrition 0.000 claims description 4
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 claims description 4
- 239000004375 Dextrin Substances 0.000 claims description 3
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 229920001100 Polydextrose Polymers 0.000 claims description 3
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 3
- 239000001527 calcium lactate Substances 0.000 claims description 3
- 235000011086 calcium lactate Nutrition 0.000 claims description 3
- 229960002401 calcium lactate Drugs 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 3
- 235000004213 low-fat Nutrition 0.000 claims description 3
- 239000001259 polydextrose Substances 0.000 claims description 3
- 235000013856 polydextrose Nutrition 0.000 claims description 3
- 229940035035 polydextrose Drugs 0.000 claims description 3
- 235000010352 sodium erythorbate Nutrition 0.000 claims description 3
- 239000004320 sodium erythorbate Substances 0.000 claims description 3
- 235000019832 sodium triphosphate Nutrition 0.000 claims description 3
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 claims description 3
- 229920001817 Agar Polymers 0.000 claims description 2
- 244000099147 Ananas comosus Species 0.000 claims description 2
- 235000007119 Ananas comosus Nutrition 0.000 claims description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- 240000000560 Citrus x paradisi Species 0.000 claims description 2
- 235000010469 Glycine max Nutrition 0.000 claims description 2
- 240000000851 Vaccinium corymbosum Species 0.000 claims description 2
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 2
- 239000008272 agar Substances 0.000 claims description 2
- 235000021014 blueberries Nutrition 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 235000015165 citric acid Nutrition 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 239000012982 microporous membrane Substances 0.000 claims description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 2
- 150000002482 oligosaccharides Chemical class 0.000 claims description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 235000017550 sodium carbonate Nutrition 0.000 claims description 2
- 229960001790 sodium citrate Drugs 0.000 claims description 2
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 claims description 2
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 claims description 2
- 235000019982 sodium hexametaphosphate Nutrition 0.000 claims description 2
- 229940048086 sodium pyrophosphate Drugs 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- 235000019818 tetrasodium diphosphate Nutrition 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims 1
- 239000003623 enhancer Substances 0.000 claims 1
- 239000003002 pH adjusting agent Substances 0.000 claims 1
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 abstract description 7
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract description 5
- 244000131316 Panax pseudoginseng Species 0.000 abstract description 5
- 238000001514 detection method Methods 0.000 description 17
- 235000013616 tea Nutrition 0.000 description 13
- 239000000243 solution Substances 0.000 description 12
- 239000000203 mixture Substances 0.000 description 8
- DJSISFGPUUYILV-UHFFFAOYSA-N UNPD161792 Natural products O1C(C(O)=O)C(O)C(O)C(O)C1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 DJSISFGPUUYILV-UHFFFAOYSA-N 0.000 description 5
- 235000013350 formula milk Nutrition 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 235000013336 milk Nutrition 0.000 description 5
- 239000008267 milk Substances 0.000 description 5
- 210000004080 milk Anatomy 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- DJSISFGPUUYILV-ZFORQUDYSA-N scutellarin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 DJSISFGPUUYILV-ZFORQUDYSA-N 0.000 description 5
- 239000003765 sweetening agent Substances 0.000 description 5
- 229920001202 Inulin Polymers 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000000378 dietary effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 4
- 229940029339 inulin Drugs 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 108010079058 casein hydrolysate Proteins 0.000 description 3
- 238000007865 diluting Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000011049 pearl Substances 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 235000014347 soups Nutrition 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 241001365741 Lithocarpus litseifolius Species 0.000 description 2
- WVXIMWMLKSCVTD-JLRHFDOOSA-N Mogroside II-E Chemical compound O([C@H](CC[C@@H](C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC4)(C)C)=CC[C@H]3[C@]2(C)CC1)C)C(C)(C)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O WVXIMWMLKSCVTD-JLRHFDOOSA-N 0.000 description 2
- 235000008599 Poria cocos Nutrition 0.000 description 2
- 244000197580 Poria cocos Species 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 108010046377 Whey Proteins Proteins 0.000 description 2
- 102000007544 Whey Proteins Human genes 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000005374 membrane filtration Methods 0.000 description 2
- WVXIMWMLKSCVTD-UHFFFAOYSA-N mogroside II E Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(CO)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC(C(C)(C)O)OC1OC(CO)C(O)C(O)C1O WVXIMWMLKSCVTD-UHFFFAOYSA-N 0.000 description 2
- 239000002114 nanocomposite Substances 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000002798 spectrophotometry method Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- GWHCXVQVJPWHRF-KTKRTIGZSA-N (15Z)-tetracosenoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-KTKRTIGZSA-N 0.000 description 1
- GHBNZZJYBXQAHG-KUVSNLSMSA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6r)-6-[[(3s,8s,9r,10r,11r,13r,14s,17r)-17-[(2r,5r)-5-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-3-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H](CC[C@@H](C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@H]3[C@]2(C)CC1)C)C(C)(C)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GHBNZZJYBXQAHG-KUVSNLSMSA-N 0.000 description 1
- 244000247812 Amorphophallus rivieri Species 0.000 description 1
- 235000001206 Amorphophallus rivieri Nutrition 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010002869 Anxiety symptoms Diseases 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 240000006162 Chenopodium quinoa Species 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000001689 FEMA 4674 Substances 0.000 description 1
- UFNDONGOJKNAES-UHFFFAOYSA-N Ginsenoside Rb1 Natural products CC(=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CC(O)C45C)C UFNDONGOJKNAES-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- JGFBQFKZKSSODQ-UHFFFAOYSA-N Isothiocyanatocyclopropane Chemical compound S=C=NC1CC1 JGFBQFKZKSSODQ-UHFFFAOYSA-N 0.000 description 1
- 229920002752 Konjac Polymers 0.000 description 1
- DATAGRPVKZEWHA-UHFFFAOYSA-N L-gamma-glutamyl-n-ethylamine Natural products CCNC(=O)CCC(N)C(O)=O DATAGRPVKZEWHA-UHFFFAOYSA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 244000042664 Matricaria chamomilla Species 0.000 description 1
- 235000004429 Matricaria chamomilla var recutita Nutrition 0.000 description 1
- 235000005135 Micromeria juliana Nutrition 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- XJXROGWVRIJYMO-SJDLZYGOSA-N Nervonic acid Natural products O=C(O)[C@@H](/C=C/CCCCCCCC)CCCCCCCCCCCC XJXROGWVRIJYMO-SJDLZYGOSA-N 0.000 description 1
- 235000001188 Peltandra virginica Nutrition 0.000 description 1
- 229940126902 Phlorizin Drugs 0.000 description 1
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 1
- 235000005805 Prunus cerasus Nutrition 0.000 description 1
- 244000207449 Prunus puddum Species 0.000 description 1
- 235000009226 Prunus puddum Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000007315 Satureja hortensis Nutrition 0.000 description 1
- 240000002114 Satureja hortensis Species 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 229930182647 Trilobatin Natural products 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- YURJSTAIMNSZAE-UHFFFAOYSA-N UNPD89172 Natural products C1CC(C2(CC(C3C(C)(C)C(O)CCC3(C)C2CC2O)OC3C(C(O)C(O)C(CO)O3)O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O YURJSTAIMNSZAE-UHFFFAOYSA-N 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960004543 anhydrous citric acid Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- PWLNAUNEAKQYLH-UHFFFAOYSA-N butyric acid octyl ester Natural products CCCCCCCCOC(=O)CCC PWLNAUNEAKQYLH-UHFFFAOYSA-N 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- GWHCXVQVJPWHRF-UHFFFAOYSA-N cis-tetracosenoic acid Natural products CCCCCCCCC=CCCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-UHFFFAOYSA-N 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 210000003022 colostrum Anatomy 0.000 description 1
- 235000021277 colostrum Nutrition 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 description 1
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 description 1
- PWAOOJDMFUQOKB-WCZZMFLVSA-N ginsenoside Re Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@](C)(CCC=C(C)C)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O PWAOOJDMFUQOKB-WCZZMFLVSA-N 0.000 description 1
- YURJSTAIMNSZAE-HHNZYBFYSA-N ginsenoside Rg1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YURJSTAIMNSZAE-HHNZYBFYSA-N 0.000 description 1
- CBEHEBUBNAGGKC-UHFFFAOYSA-N ginsenoside Rg1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CC(OC6OC(CO)C(O)C(O)C6O)C34C)C CBEHEBUBNAGGKC-UHFFFAOYSA-N 0.000 description 1
- AOGZLQUEBLOQCI-UHFFFAOYSA-N ginsenoside-Re Natural products CC1OC(OCC2OC(OC3CC4(C)C(CC(O)C5C(CCC45C)C(C)(CCC=C(C)C)OC6OC(CO)C(O)C(O)C6O)C7(C)CCC(O)C(C)(C)C37)C(O)C(O)C2O)C(O)C(O)C1O AOGZLQUEBLOQCI-UHFFFAOYSA-N 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000000252 konjac Substances 0.000 description 1
- 235000010485 konjac Nutrition 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229940074968 melissa officinalis extract Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- TVJXHJAWHUMLLG-UHFFFAOYSA-N mogroside V Natural products CC(CCC(OC1OC(COC2OC(CO)C(O)C(O)C2OC3OC(CO)C(O)C(O)C3O)C(O)C(O)C1O)C(C)(C)O)C4CCC5(C)C6CC=C7C(CCC(OC8OC(COC9OC(CO)C(O)C(O)C9O)C(O)C(O)C8O)C7(C)C)C6(C)C(O)CC45C TVJXHJAWHUMLLG-UHFFFAOYSA-N 0.000 description 1
- 229940082477 moringa oleifera leaf extract Drugs 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- UUIQMZJEGPQKFD-UHFFFAOYSA-N n-butyric acid methyl ester Natural products CCCC(=O)OC UUIQMZJEGPQKFD-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- IOUVKUPGCMBWBT-UHFFFAOYSA-N phloridzosid Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-UHFFFAOYSA-N 0.000 description 1
- IOUVKUPGCMBWBT-GHRYLNIYSA-N phlorizin Chemical compound O[C@@H]1[C@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-GHRYLNIYSA-N 0.000 description 1
- 235000019139 phlorizin Nutrition 0.000 description 1
- 229940075999 phytosterol ester Drugs 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000021092 sugar substitutes Nutrition 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- GSTCPEBQYSOEHV-QNDFHXLGSA-N trilobatin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 GSTCPEBQYSOEHV-QNDFHXLGSA-N 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/30—Further treatment of dried tea extract; Preparations produced thereby, e.g. instant tea
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention relates to a dietary supplement beverage containing panax notoginseng saponins, mogroside and theanine and a preparation process thereof, belonging to the field of food. The dietary supplement beverage comprises the following components in parts by weight: 150000-500000 parts of water, 35-60 parts of panax notoginseng saponins, 15-30 parts of mogrosides, 30-55 parts of theanine, 3500-00 parts of water-soluble dietary fibers, 50-90 parts of color assisting agents and 50-90 parts of pH regulators. The preparation method comprises the following steps: weighing pseudo-ginseng flower, pseudo-ginseng stem leaf or pseudo-ginseng extract, momordica grosvenori or momordica grosvenori extract, green tea, black tea, green tea extract and black tea extract according to weight parts, adding water according to weight parts, and decocting for 30 min; secondly, centrifuging or filtering, adding water-soluble dietary fiber, a color assisting agent and a pH regulator into the filtrate according to the parts by weight, fully dissolving, and regulating the pH of the solution to 5-8; filtering, and filling the filtrate in an aluminum tank or an iron tank; fourthly, sterilizing.
Description
Technical Field
The invention relates to a dietary supplement beverage containing panax notoginseng saponins, mogrosides and theanine and a preparation process thereof, belonging to the field of food.
Background
Chinese patent application No. 201610319820.6 discloses a breviscapine and panax notoginseng saponins double nano-composite particle and a preparation method and application thereof. Wherein, the weight ratio of the total saponins of panax notoginseng is 50 to 200 percent, and the weight ratio of the protective agent is 100 to 200 percent. The double nano composite particle is used for preparing cardiovascular and cerebrovascular diseases.
Chinese patent application No. 200510010738.7 discloses a pharmaceutical preparation for treating cerebral thrombosis, coronary heart disease and angina pectoris, which is prepared from 5-95% of total saponins of Notoginseng radix and breviscapine, and the balance of adjuvants.
Chinese patent application No. 03104665.7 discloses a medicinal composition containing 1.5-100 parts of total saponins of panax notoginseng and 1 part of breviscapine for treating cardiovascular and cerebrovascular diseases.
Chinese patent application No. 201310213513.6 discloses a composition for treating coronary heart disease containing Panax notoginseng saponins and breviscapine 1:1-1:5, wherein ginsenoside-Rb 1, ginsenoside-Rg 1 are more than 30%, and Panax notoginseng saponins-R1 are more than 5%, and the total content is more than 60%.
Chinese patent application No. 201710106679.6 discloses a composition comprising nervonic acid 24-60 parts, Panax notoginsenosides 48-90 parts and breviscapine 10-38 parts.
Chinese patent application No. 202110248430.5 discloses a food formula for relieving pressure and resisting anxiety and a preparation method thereof, which is characterized in that the food formula consists of soft-core pearls and tea soup, and the shape of the food formula looks like pearl milk tea; the soft-core pearls and the tea soup are added in an amount of 10-20 g per 600-800 mL of tea soup. The sweetener can be one or more of white sugar, soft white sugar, xylitol, erythritol, mogroside, stevioside and other commercialized sugar substitute products, and the dosage is adjusted according to the sweetness of the sweetener.
Chinese patent application No. 202010471878.9 discloses an application of mogroside IIE in preparing anti-inflammatory food, health products or medicines.
Chinese patent application No. 202010471884.4 discloses an application of mogroside IIE in preparing antioxidant food, health products or medicines.
Chinese patent application No. 201910623559.2 discloses a preparation method of edible sweet granules for diabetics: dissolving fructus Siraitiae Grosvenorii extract 0.1-0.5 parts and Lithocarpus litseifolius extract 0.3-0.8 parts in 10-30 parts of 80 deg.C 50% ethanol water, stirring to dissolve completely to obtain sweetener solution; the mass fraction of mogroside V in the fructus momordicae extract is not less than 90%; the lithocarpus litseifolius extract contains 35% of phlorizin and 65% of trilobatin by mass.
Chinese patent application No. 202111554545.3 discloses a plant beverage for improving sleep and a preparation method thereof, which takes medicinal and edible raw materials (blighted wheat, spina date seed, Chinese date, tuckahoe and liquorice) as the basis, and casein hydrolysate peptide and new resource food (gamma-aminobutyric acid and tea theanine) are added to synergistically improve sleep.
Chinese patent application No. 202111514395.3 discloses a nutritious milk powder with health care function for reducing high blood pressure, high blood sugar and resisting cancer, the nutrients comprise 30% of inulin, 20% of phytosterol ester, 20% of lotus leaf powder, 10% of hawthorn powder, 10% of yam powder, 2% of tea leaf and tea amino acid powder and 8% of selenium-enriched yeast.
Chinese patent application No. 202111349841.X discloses a formula milk powder for improving immunity, strengthening muscles and bones and helping sleep and a preparation method thereof, and the formula comprises milk powder, solid corn syrup, defatted whey powder, inulin, isomaltooligosaccharide, whey protein powder, lactoferrin, hydrolyzed egg yolk powder, colostrum basic protein, beta-hydroxy-beta-calcium methylbutyrate, L-theanine, low-fat xylose, compound microorganisms, medicinal and edible powder and organic selenium.
Chinese patent application No. 202111342543.8 discloses a composition with effects of promoting sleep and skin repair and application thereof in cosmetics, wherein the composition with effects of promoting sleep and skin repair comprises theanine, camellia extract and quinoa seed extract.
Chinese patent application No. 202111237816.2 discloses an absorption type functional sleep jelly and a production process thereof, wherein the absorption type functional sleep jelly comprises the following components in percentage by mass: 0.15% of stabilizer, 0.1% of konjac flour, 0.05% of carrageenan, 0.05% of sodium citrate, 1.75% of white granulated sugar, 77.88% of water, 0.15% of calcium lactate solution, 7% of fruit juice, 0.03% of VC, 0.5% of GABA, 0.3% of theanine, 0.3% of spina date seed powder, 1% of casein hydrolysate peptide, 0.01% of melissa officinalis extract, 0.15% of German chamomile extract and 0.33% of anhydrous citric acid.
Chinese patent application No. 202111261662.0 discloses a modified milk powder for improving sleep, which comprises 900 parts of milk product 700 plus materials, 2-30 parts of moringa oleifera leaf extract, 5-30 parts of spina date seed extract, 1-20 parts of poria cocos extract, 10-50 parts of red date powder, 1-20 parts of sour cherry powder, 1-20 parts of tea theanine, 1-20 parts of casein hydrolysate peptide and 4-20 parts of vitamins and minerals.
Just like food and beverages consumed on a daily basis, it is desirable that dietary nutritional supplements also provide the same aesthetic experience. In addition to having functional nutritional benefits, consumers desire dietary nutritional supplements that are both convenient and palatable. In many cases, consumers will choose products that are both savory and nutritious in order to enjoy more enjoyment. This "purposeful enjoyment" concept makes the dietary nutritional supplement market highly desirable because 58% of the global consumers indicate that the dietary nutritional supplement also needs to be "good for eating".
Disclosure of Invention
The invention aims to provide a dietary supplement beverage consisting of components with homology of medicine and food.
It is another object of the present invention to provide a method for preparing such a beverage.
The dietary supplement beverage comprises the following components in parts by weight: 500000 parts of water 150000-.
Preferably, the beverage comprises the following components by weight: 200000-.
The Notoginseng radix total saponin is food grade Notoginseng radix total saponin, or at least one of Notoginseng radix flower, Notoginseng radix stem and leaf, and Notoginseng radix flower and leaf extract
The mogroside is food-grade mogroside sold on the market, or at least one of extracts from fructus momordicae and fructus momordicae.
The theanine is food-grade theanine sold in the market, or is derived from at least one of green tea, black tea, green tea extract and black tea extract.
The water-soluble dietary fiber is at least one of polydextrose, low-fat pectin, high-fat pectin, apple pectin, pomelo peel pectin, blueberry pectin, pineapple pectin, fructo-oligosaccharide, isomalto-oligosaccharide, lacto-oligosaccharide, xylo-oligosaccharide, soybean oligosaccharide, agar powder, carboxymethyl cellulose and resistant dextrin.
The color-assisting agent is at least one of sodium tripolyphosphate, sodium pyrophosphate, sodium hexametaphosphate, sodium citrate, phytic acid, sodium erythorbate and calcium lactate.
The pH regulator is at least one of sodium carbonate, sodium bicarbonate, citric acid, sodium citrate, potassium dihydrogen phosphate and dipotassium hydrogen phosphate.
The preparation method of the dietary supplement beverage comprises the following steps:
weighing Notoginseng flower, Notoginseng stem and leaf or Notoginseng radix extract containing Notoginseng radix total saponin, fructus Siraitiae Grosvenorii or fructus Siraitiae Grosvenorii extract containing mogroside, green tea containing theanine, black tea, green tea extract, black tea extract, adding water, and decocting for 30 min;
secondly, centrifuging or filtering, adding water-soluble dietary fiber, a color assisting agent and a pH regulator into the filtrate according to parts by weight, fully dissolving, and regulating the pH of the solution to 5-8;
filtering, and filling the filtrate in an aluminum tank or an iron tank;
fourthly, sterilization: sterilizing the filled aluminum can or iron can with 121 deg.C steam for 20-30min, or filtering with 0.22 μm microporous membrane, and aseptically filling with PE bottle.
Preferably, a preservative may be added in an amount of 0.2 to 1% by weight of the solution.
The invention has the following beneficial effects:
1. the invention organically combines the pharmacodynamic mechanism and the physiological health care function of the panax notoginseng saponins, the mogroside and the theanine, and the efficacy is cooperatively exerted under the three conditions, so that the health care function is exerted stably and stably for a long time, and the aim of treating and preventing hypertension, hyperglycemia and hyperlipidemia is fulfilled.
2. The invention has the functions of quenching thirst and certain excellent mouthfeel, has the functions of reducing blood pressure, blood fat and blood sugar, and can be used as a dietary supplement for people with hypertension, hyperlipidemia and hyperglycemia.
3. According to the invention, sugar and other sweeteners are not used on the premise of improving the mouthfeel, the sweet taste is derived from notoginsenoside, notoginseng flower, notoginseng stem and leaf or extract thereof, mogroside, momordica grosvenori or extract thereof, and the good mouthfeel is obtained, and meanwhile, the phenomenon that the control of three highs is not facilitated due to excessive sugar intake is avoided.
4. The invention can reduce three highs, and has the practical effects of relieving anxiety symptom, improving sleep quality and the like.
Experimental analysis:
detection of total saponin and theanine
1. Detection of total saponins:
panax notoginseng saponins and mogroside belong to total saponins, and the total saponins and the mogroside are respectively detected according to spectrophotometry of total saponins in Baihong detection method of functional ingredients of health food.
1.1 sample preparation:
1.1.1 solid sample
Weighing 1g of uniformly crushed solid sample into a 100mL beaker, adding 20-40mL of 85% ethanol solution, carrying out ultrasonic oscillation for 30min, then carrying out constant volume to 50mL, shaking up, standing, sucking 1.0mL of supernatant, dissolving the residue with water after volatilizing, and carrying out column separation.
1.1.2 liquid sample
1.0mL of liquid sample (1.0 mL after dilution of a certain volume if the concentration is high or the color is dark) is sucked and directly subjected to column separation.
1.2 preparation of standard:
weighing ginsenoside Re, preparing into 0.5mg/ml solution, and diluting to 1 time, 2 times, 3 times, 4 times, 5 times, and 6 times.
1.3, sample detection:
three samples of notoginseng flower and leaf, notoginseng flower and leaf extract, momordica grosvenori and momordica grosvenori extract are respectively taken in parallel, two kinds of saponins are respectively detected according to spectrophotometry of total saponins in Baihong detection method of health food efficacy component, the average value of the detection results is calculated, and the detection results are used as the calculation basis of the following embodiment:
TABLE 1 examination results of Panax notoginsenosides and mogrosides
2. Detection of theanine
The theanine is detected according to the detection method of GBT23193-2017 high performance liquid chromatography for detecting theanine in tea.
2.1 instruments and reagents.
2.1.1 high performance liquid chromatograph: comprises gradient elution, an ultraviolet detector and a chromatographic workstation;
2.1.2 theanine standards: purity: 99.6%, available from chemical company;
2.1.3 HPLC mobile phase: mobile phase A: 100% pure water, mobile phase B: 100% acetonitrile;
2.1.4 theanine standard stock solutions:
weighing 0.05g of theanine, dissolving the theanine with water, transferring the dissolved theanine into a 50ml volumetric flask, diluting to a scale, and uniformly mixing; 2.1.5 theanine standard use solutions:
accurately sucking out 0ml, 0.1ml, 0.2ml, 0.5ml, 1.0ml, 1.5ml and 2.0ml of theanine standard stock solution respectively, and diluting to 10ml with water to obtain theanine standard use solutions with concentrations of 0.0mg/ml, 0.01mg/ml, 0.02mg/ml, 0.05mg/ml, 0.1mg/ml, 0.15mg/ml and 0.20mg/ml respectively.
2.2 sample treatment:
after grinding and mixing the tea sample, 1.0g (exactly to 0.01g) is weighed into a 200ml beaker, and 100ml of boiling distilled water is added. Leaching in 100 deg.C constant temperature water bath for 30min, filtering, transferring into 100ml volumetric flask, cooling, adding water to desired volume, and mixing. The mixture was filtered through a 0.45 μm filter and then subjected to liquid phase analysis.
2.3, detection:
two samples of tea and tea extract are respectively taken in parallel, and the theanine is detected according to a detection method of GBT23193-2017 high performance liquid chromatography for detecting theanine in tea, wherein the detection results are as follows:
2.4 results:
table 2 detection results of theanine:
and secondly, the taste and appearance of the three functional components are tested:
1. taste and appearance test of three functional ingredients
The three components of the panax notoginseng saponins, the mogroside and the theanine are singly prepared or compounded into an aqueous solution, and the taste and appearance are tested, and the results are shown in the following table:
TABLE 3 taste and appearance test of three ingredients singly or in combination
2. Taste and appearance test of raw materials containing three functional components
The panax notoginseng saponins, the mogrosides and the theanine are respectively characteristic components of panax notoginseng flower leaves, momordica grosvenori and green tea, raw materials containing the panax notoginseng saponins, the mogrosides and the theanine are extracted by boiling water and are singly prepared or compounded into aqueous solution, and the results of the taste and appearance inspection are shown in the following table:
TABLE 4 taste and appearance test of three raw materials singly or compounded
Detailed Description
The following preferred embodiments are provided in detail to enable those skilled in the art to more clearly understand the technical solutions and effects of the present invention.
Example 1:
1. weighing Notoginseng flower 9.69g, fructus Siraitiae Grosvenorii 104.0g, and green tea 37.94g, respectively, adding purified water about 500 times, decocting for 30min,
2. centrifuging, and adding 266.0g of polydextrose, 2.0g of sodium tripolyphosphate and 2.0g of dipotassium phosphate into the supernate;
3.0.45 μm filter membrane filtration, and the filtrate is fixed to 10000 ml;
4. filling the mixture into a 310ml aluminum can, wherein the filling volume is 280ml, and 35 bottles in total are filled;
5. sterilizing the filled beverage with 121 deg.C steam for 20-30 min.
Through detection, each can of beverage contains 38mg of panax notoginseng saponins, 15mg of mogroside and 55mg of theanine.
Example 2:
1. respectively weighing 12.88g of Notoginseng radix stem and leaf extract, 23.33g of fructus Siraitiae Grosvenorii extract, and 102.0g of green tea extract, adding 500 times of purified water, and decocting for 30 min;
2. centrifuging, and adding inulin 125.0g, phytic acid 3.2g, and sodium bicarbonate 3.2g into the supernatant;
3.0.45 μm filter membrane filtration, and the filtrate is fixed to 10000 ml;
4. filling the mixture into a 310ml aluminum can, wherein the filling volume is 280ml, and 35 bottles in total are filled;
5. sterilizing the filled beverage with 121 deg.C steam for 20-30 min.
Through detection, each can of beverage contains 55mg of panax notoginseng saponins, 30mg of mogroside and 30mg of theanine.
Example 3:
1. respectively weighing 1428mg of panax notoginseng saponins, 892.5mg of mogroside, 1500mg of theanine, 5247.9g of inulin, 87.5g of phytic acid and 93.7g of sodium bicarbonate, and fixing the volume to 10000 ml;
2. hot spraying, spraying and sterilizing of beverage bottles: keeping the PE bottle at 85 ℃ for more than 15min, and keeping the PE bottle in a sterile state;
3. sterilizing and filtering the prepared solution twice with a 0.22 μm filter membrane, and filling the filtrate in a sterilized PE bottle.
Through detection, each can of the beverage contains 40mg of panax notoginseng saponins, 25mg of mogrosides and 42mg of theanine.
Example 4:
1. respectively weighing 12.75g of pseudo-ginseng flower and leaf, 208.0g of momordica grosvenori and 1.25g of theanine, adding purified water with the amount about 500 times that of the pseudo-ginseng flower and leaf, and decocting for 30 min;
2. adding 142.8g of resistant dextrin, 2.1g of sodium erythorbate and 2.6g of sodium bicarbonate, and fixing the volume to 10000 ml;
3. hot spraying, spraying and sterilizing of beverage bottles: keeping the PE bottle at 85 ℃ for more than 15min, and keeping the PE bottle in a sterile state;
4. sterilizing and filtering the prepared solution twice with a 0.22 μm filter membrane, and filling the filtrate in a sterilized PE bottle.
Detection shows that each can of beverage contains 50mg of panax notoginseng saponins, 30mg of mogroside and 35mg of theanine.
While the invention has been described with reference to a preferred embodiment, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the spirit and scope of the invention. However, any simple modification, equivalent change and dosage form of the above embodiments according to the technical essence of the present invention still fall within the protection scope of the technical solution of the present invention.
Claims (9)
1. A dietary supplement beverage is characterized by comprising the following components in parts by weight: 150000-500000 parts of water, 35-60 parts of panax notoginseng saponins, 15-30 parts of mogrosides, 30-55 parts of theanine, 3500-00 parts of water-soluble dietary fibers, 50-90 parts of color assisting agents and 50-90 parts of pH regulators.
2. A dietary supplement beverage as claimed in claim 1 comprising the following components in parts by weight: 200000-.
3. A dietary supplement beverage as claimed in claims 1 and 2, wherein said Panax notoginsenosides are commercially available food grade Panax notoginsenosides, or are derived from at least one of extracts of Notoginseng, stems and leaves of Notoginseng, and leaves of Notoginseng.
4. A dietary supplement beverage according to claims 1 and 2, wherein said mogrosides are commercially available food grade mogrosides or are derived from at least one of luo han guo, luo han guo extract.
5. A dietary supplement beverage according to claims 1 and 2, characterised in that said theanine is commercially available food grade theanine or is derived from at least one of green tea, black tea, green tea extract, black tea extract.
6. A dietary supplement beverage according to claims 1 and 2 wherein said water soluble dietary fiber is at least one of polydextrose, low fat pectin, high fat pectin, apple pectin, grapefruit peel pectin, blueberry pectin, pineapple pectin, fructo-oligosaccharides, isomalto-oligosaccharides, lacto-oligosaccharides, xylo-oligosaccharides, soy oligosaccharides, agar powder, carboxymethyl cellulose, resistant dextrins.
7. A dietary supplement beverage as in claims 1 and 2 wherein said color enhancer is at least one of sodium tripolyphosphate, sodium pyrophosphate, sodium hexametaphosphate, sodium citrate, phytic acid, sodium erythorbate, and calcium lactate.
8. A dietary supplement beverage according to claims 1 and 2, characterised in that said pH modifier is at least one of sodium carbonate, sodium bicarbonate, citric acid, sodium citrate, potassium dihydrogen phosphate, dipotassium hydrogen phosphate.
9. A method of preparing a dietary supplement beverage as claimed in claims 1 and 2, comprising the steps of:
weighing Notoginseng flower, Notoginseng stem and leaf or Notoginseng radix extract containing Notoginseng radix total saponin, fructus Siraitiae Grosvenorii or fructus Siraitiae Grosvenorii extract containing mogroside, green tea containing theanine, black tea, green tea extract, black tea extract, adding water, and decocting for 30 min;
secondly, centrifuging or filtering, adding water-soluble dietary fiber, a color assisting agent and a pH regulator into the filtrate according to the parts by weight, fully dissolving, and regulating the pH of the solution to 5-8;
filtering, and filling the filtrate in an aluminum tank or an iron tank;
fourthly, sterilization: sterilizing the filled aluminum can or iron can with 121 deg.C steam for 20-30min, or filtering with 0.22 μm microporous membrane, and aseptically filling with PE bottle.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210514918.2A CN115005344A (en) | 2022-05-12 | 2022-05-12 | Dietary supplement beverage and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210514918.2A CN115005344A (en) | 2022-05-12 | 2022-05-12 | Dietary supplement beverage and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115005344A true CN115005344A (en) | 2022-09-06 |
Family
ID=83069824
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210514918.2A Pending CN115005344A (en) | 2022-05-12 | 2022-05-12 | Dietary supplement beverage and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115005344A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1372852A (en) * | 2001-02-28 | 2002-10-09 | 金光管理咨询(上海)有限公司 | Momordica grosvenoric tea beverage and its preparing process |
CN104814191A (en) * | 2015-04-16 | 2015-08-05 | 萧氏饮品有限公司 | Theanine-rich fruit tea beverage and preparation method thereof |
CN106343090A (en) * | 2016-09-28 | 2017-01-25 | 湖南华诚生物资源股份有限公司 | Fructus siraitiae, prebiotic and chrysanthemum flower tea instant beverage and preparation method thereof |
CN106720745A (en) * | 2016-12-01 | 2017-05-31 | 昆明理工大学 | A kind of notoginseng flower for improving the health care of sleep and preparation method thereof |
CN111109510A (en) * | 2020-01-21 | 2020-05-08 | 正大青春宝药业有限公司 | Natural compound composition and preparation and application thereof |
-
2022
- 2022-05-12 CN CN202210514918.2A patent/CN115005344A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1372852A (en) * | 2001-02-28 | 2002-10-09 | 金光管理咨询(上海)有限公司 | Momordica grosvenoric tea beverage and its preparing process |
CN104814191A (en) * | 2015-04-16 | 2015-08-05 | 萧氏饮品有限公司 | Theanine-rich fruit tea beverage and preparation method thereof |
CN106343090A (en) * | 2016-09-28 | 2017-01-25 | 湖南华诚生物资源股份有限公司 | Fructus siraitiae, prebiotic and chrysanthemum flower tea instant beverage and preparation method thereof |
CN106720745A (en) * | 2016-12-01 | 2017-05-31 | 昆明理工大学 | A kind of notoginseng flower for improving the health care of sleep and preparation method thereof |
CN111109510A (en) * | 2020-01-21 | 2020-05-08 | 正大青春宝药业有限公司 | Natural compound composition and preparation and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5455235A (en) | Food composition for inhibiting the formation of an intestinal putrefactive product | |
KR101326005B1 (en) | Functional beverage composition comprising Panax Ginseng concentrate and fruit concentrate | |
CN113180165A (en) | Beautifying beverage containing sodium hyaluronate and preparation method thereof | |
CN110477352A (en) | A kind of mogroside of suitable diabetes patient is for sugar and preparation method thereof | |
KR101158506B1 (en) | Fermented ginseng yoghurt drink composition and preparation method thereof | |
CN112120204A (en) | Sweet composition for reducing blood fat and preparation method thereof | |
KR100759222B1 (en) | Method for preparing a drink with red ginseng and vinegar | |
CN105558056A (en) | Inonotus obliquus milk tea powder and preparation method thereof | |
KR20170056597A (en) | A flavor modifying composition, uses thereof and products comprising the same | |
EP2292103A1 (en) | Sweetening composition | |
US20090162511A1 (en) | Natural sweetner comprising powdered luo han guo whole fruit extracts | |
CN106359734A (en) | Sugar-free tea drink with weight-losing function and making method thereof | |
KR20190091768A (en) | Health assistance food for promoting growth | |
KR100555652B1 (en) | Extract of processed Panax Species plant, process for preparing the same, and composition containing the same for preventing and treating cancer and allergy- mediated disease | |
CN111357891A (en) | Plant beverage containing artichoke and ginseng and preparation method thereof | |
CN115005344A (en) | Dietary supplement beverage and preparation method thereof | |
CN115606730A (en) | Sweet beverage added with erythritol and preparation method thereof | |
KR100919134B1 (en) | Extract of antiobestic ginseng with anti-obesity effect comprising high concentration of less polar ginsenoid and method of preparing the same | |
CN106581115A (en) | Composition containing brassica rapa.L and ginseng and application of composition | |
KR20100025303A (en) | Functional beverage composition in which the function of ginseng saponin is augmented | |
KR101470337B1 (en) | Concentrated functionality drink comprising unripened black raspberry and manufacturing method thereof | |
KR20220087888A (en) | Black bellflower syrup and method of preparing therefor | |
CN110800893A (en) | Sucrose-free beverage with effects of reducing blood fat, reducing weight, promoting digestion, clearing heat, tonifying spleen, promoting diuresis and reducing blood sugar and preparation method thereof | |
KR101741171B1 (en) | Water jelly type food comprising Allium hookeri extract and red ginseng extracts, and the production thereof | |
CN107536008A (en) | Steviol glycoside compound sweetener |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220906 |